Quick Answer
ARTELO BIOSCIENCES, INC. reported Operating Income Loss of -$11.40 million for the year ending 2025.
- ARTELO BIOSCIENCES, INC. showed a decrease of -12.8% in Operating Income Loss from 2024 to 2025.
- This data is from ARTELO BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2014 to 2025), ARTELO BIOSCIENCES, INC.'s Operating Income Loss has declined by 74,587.3%.
- Historical annual values: Fiscal year 2025: -$11.40 million | Fiscal year 2024: -$10.11 million | Fiscal year 2023: -$9.93 million | Fiscal year 2022: -$10.29 million | Fiscal year 2021: -$9.42 million | Fiscal year 2021: -$7.44 million | Fiscal year 2020: -$4.69 million | Fiscal year 2019: -$3.21 million | Fiscal year 2018: -$2.34 million | Fiscal year 2017: -$232.8 thousand | Fiscal year 2016: -$29.7 thousand | Fiscal year 2015: -$15.2 thousand | Fiscal year 2014: -$15.3 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: